This report contains market size and forecasts of BCG Vaccine in China, including the following market information:
China BCG Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
China BCG Vaccine Market Sales, 2016-2021, 2022-2027, (MT)
China top five BCG Vaccine companies in 2020 (%)
The global BCG Vaccine market size is expected to growth from US$ 355.1 million in 2020 to US$ 518.2 million by 2027; it is expected to grow at a CAGR of 5.6% during 2021-2027.
The China BCG Vaccine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the BCG Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China BCG Vaccine Market,

By Type

, 2016-2021, 2022-2027 ($ Millions) & (MT)
China BCG Vaccine Market Segment Percentages,

By Type

, 2020 (%)
Immune BCG
Therapy BCG

China BCG Vaccine Market,

By Application

, 2016-2021, 2022-2027 ($ Millions) & (MT)
China BCG Vaccine Market Segment Percentages,

By Application

, 2020 (%)
Hospitals
Clinics
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies BCG Vaccine revenues share in China market, 2020 (%)
Key companies BCG Vaccine sales in China market, 2016-2021 (Estimated), (MT)
Key companies BCG Vaccine sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL